Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Xbrane Biopharma obtains GMP certification for Spherotide production facility
Tuesday, February 21, 2017Xbrane Biopharma has been granted GMP Good Manufacturing Practice certification for its Spherotide production facility by AIFA the Italian Medicines Agency The GMP certification follows an inspection by AIFA where the production facility was found to...
ICON Selected by the FDA to Validate Patient-Reported Outcome Endpoints for Antibacterial Drug Trials
Tuesday, February 21, 2017ICON plc a global provider of drug development solutions and services to the pharmaceutical biotechnology and medical device industries today announced that it has been awarded a project by the US Food Drug Administration FDA to validate three Patie...
CTT Pharmaceutical Holdings and CanniMed Therapeutics Inc. Complete Exclusive Canadian Licensing Agreement
Monday, February 20, 2017Today CanniMed Therapeutics Inc and CTT Pharmaceutical Holdings Inchave entered into a definitive contractual relationship for the licensing of CTTs Orally Dissolvable Thin Film ODF Wafer technology This industryfirst collaboration includes the li...
Immune Pharmaceuticals Announces the launch of REMAIN™
Monday, February 20, 2017Immune Pharmaceuticals Inc will announce on Monday February th at the Acute Leukemia XVI symposium in Munich Germany that it will be launching REMAIN an international Overall Survival clinical study with the combination of Ceplene the Companys flags...
Health Canada Approves Otsuka and Lundbeck's REXULTI™
Saturday, February 18, 2017Otsuka Pharmaceutical Co Ltd and Lundbeck Canada announce that Health Canada issued a Notice of Compliance for REXULTI brexpiprazole for the treatment of schizophrenia in adults REXULTI was discovered by Otsuka and codeveloped with Lundbeck It will b...
Zymeworks Receives Second Orphan Drug Designation for ZW25 in Gastric Cancer
Friday, February 17, 2017Zymeworks Inc Zymeworks a clinicalstage biopharmaceutical company dedicated to the discovery development and commercialization of nextgeneration multifunctional biotherapeutics initially focused on the treatment of cancer today announced that its lea...
Dauntless Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Octreotide Formulation for Intranasal Delivery
Friday, February 17, 2017Dauntless Pharmaceuticals Inc a privately held biopharmaceutical company focused on the development of specialty therapeutics today announced the initiation of a Phase clinical study to assess the safety tolerability pharmacokinetics and pharmacodyn...
Imprimis Pharmaceuticals Begins Dispensing from FDA-Registered 503B Outsourcing Facility
Friday, February 17, 2017Imprimis Pharmaceuticals Incan ophthalmologyfocused pharmaceutical company today announced that it has begun shipping its core sterile ophthalmic medications to select customers from its FDAregistered outsourcing facility without the need for a patie...
Solasia and Lee’s Pharma Announce License, Promotion and Supply Agreement for episil®
Thursday, February 16, 2017Solasia Pharma KK and Lees Pharmaceutical Holdings Limited jointly announced today that Solasia and Lees Pharma have entered into an exclusive agreement for the commercialization and promotion of episil in the Peoples Republic of China the PRC Hong K...
Mayne Pharma Launches Butalbital Acetaminophen Tablets in The United States
Thursday, February 16, 2017Mayne Pharma Group Limited is pleased to announce the launch of butalbital acetaminophen APAP tablets mg mg in the United States Butalbital APAP is indicated for the treatment of tension headache migraine Mayne Pharma will distribute the drug on b...
